Table 1.
Test results for the differential diagnosis of LGMFS.
Feature | Description | Comparison with Other Tumors |
---|---|---|
EM | · Spindle or stellate tumor cells · Abundant microfilaments, microtubules, and collagen fibers · Reflects fibroblastic properties and active protein synthesis |
Distinguish LGMFS from fibrosarcoma, leiomyosarcoma, malignant fibrous histiocytoma, synovial sarcoma, and fibromatosis |
CD34 | · Uncommon in LGMFS | · Strong positivity in angiosarcoma |
S100 | · Negative in LGMFS | · Positive in MPNST and schwannomas |
α-SMA | · Focally positive in LGMFS | · Widespread SMA positivity in leiomyosarcoma |
STAT6 and H3 K27Me3 | · Both absent in LGMFS | · Present in SFT |
p16 and CDK4 | · Both absent in LGMFS | · Present in DFSP |
FISH | · No PDGFB translocation or COL1A1::PDGFB fusion · No MDM2 amplification |
· PDGFB translocation or COL1A1::PDGFB fusion in DFSP · MDM2 amplification in liposarcomas |
This table summarizes key features for the differential diagnosis of LGMFS, highlighting electron microscopy findings, immunohistochemical markers, and genetic differences compared to other soft tissue tumors. LGMFS, Low-grade myofibroblastic sarcoma; EM, Electron microscopy; FISH, Fluorescence in situ hybridization; SFT, Solitary fibrous tumor; DFSP, Dermatofibrosarcoma protuberans.